Advaxis, Inc. – “Advaxis Immunotherapies Complement PD-1 Antibodies”

[Accesswire] – Advaxis Inc. (NASDAQ:ADXS) today published a new blog post on The Chairman’s Blog, written by the company’s CSO, Dr. Robert Petit. TheChairmansBlog.com is an exclusive online media publication that provides … more

View todays social media effects on ADXS

View the latest stocks trending across Twitter. Click to view dashboard

See who Advaxis is hiring next, click here to view